βKlotho is required for metabolic activity of fibroblast growth factor 21

被引:514
|
作者
Ogawa, Yasushi
Kurosu, Hiroshi
Yamamoto, Masaya
Nandi, Animesh
Rosenblatt, Kevin P.
Goetz, Regina
Eliseenkova, Anna V.
Mohammadi, Moosa
Kuro-o, Makoto
机构
[1] Univ Texas, Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[2] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA
关键词
klotho; glucose; adipocyte; siRNA; GLUT1;
D O I
10.1073/pnas.0701600104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fibroblast growth factor 21 (FGF21) is a liver-derived endocrine factor that stimulates glucose uptake in adipocytes. Here, we show that FGF21 activity depends on beta Klotho, a single-pass transmembrane protein whose expression is induced during differentiation from preadipocytes to adipocytes. beta Klotho physically interacts with FGF receptors 1c and 4, thereby increasing the ability of these FGF receptors to bind FGF21 and activate the MAP kinase cascade. Knockdown of beta Klotho expression by siRNA in adipocytes diminishes glucose uptake induced by FGF21. Importantly, administration of FGF21 into mice induces MAP kinase phosphorylation in white adipose tissue and not in tissues without beta Klotho expression. Thus, beta Klotho functions as a cofactor essential for FGF21 activity.
引用
收藏
页码:7432 / 7437
页数:6
相关论文
共 50 条
  • [1] βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
    Ding, Xunshan
    Boney-Montoya, Jamie
    Owen, Bryn M.
    Bookout, Angie L.
    Coate, Katie Colbert
    Mangelsdorf, David J.
    Kliewer, Steven A.
    CELL METABOLISM, 2012, 16 (03) : 387 - 393
  • [2] Fibroblast growth factor 21 in metabolic syndrome
    Yang, Ming
    Liu, Chongbin
    Jiang, Na
    Liu, Yan
    Luo, Shilu
    Li, Chenrui
    Zhao, Hao
    Han, Yachun
    Chen, Wei
    Li, Li
    Xiao, Li
    Sun, Lin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] Metabolic actions of fibroblast growth factor 21
    Cuevas-Ramos, Daniel
    Aguilar-Salinas, Carlos A.
    Gomez-Perez, Francisco J.
    CURRENT OPINION IN PEDIATRICS, 2012, 24 (04) : 523 - 529
  • [4] Fibroblast Growth Factor 21: A Novel Metabolic Regulator
    Seo, Ji A.
    Kim, Nan Hee
    DIABETES & METABOLISM JOURNAL, 2012, 36 (01) : 26 - 28
  • [5] Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
    She, Qin-Ying
    Bao, Jing-Fu
    Wang, Hui-Zhen
    Liang, Huixin
    Huang, Wentao
    Wu, Jing
    Zhong, Yiwen
    Ling, Hanxin
    Li, Aiqing
    Qin, Shu-Lan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 130
  • [6] Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
    Adams, Andrew C.
    Coskun, Tamer
    Cheng, Christine C.
    O'Farrell, Libbey S.
    DuBois, Susan L.
    Kharitonenkov, Alexei
    MOLECULAR METABOLISM, 2013, 2 (03): : 205 - 214
  • [7] Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions
    Min, Xiaoshan
    Weiszmann, Jennifer
    Johnstone, Sheree
    Wang, Wei
    Yu, Xinchao
    Romanow, William
    Thibault, Stephen
    Li, Yang
    Wang, Zhulun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (38) : 14678 - 14688
  • [8] Fibroblast growth factor 23, klotho and heparin
    Thomas, S. Madison
    Li, Qing
    Faul, Christian
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2023, 32 (04): : 313 - 323
  • [9] Fibroblast Growth Factor 23 and Klotho in AKI
    Christov, Marta
    Neyra, Javier A.
    Gupta, Sanjeev
    Leaf, David E.
    SEMINARS IN NEPHROLOGY, 2019, 39 (01) : 57 - 75
  • [10] Relationship of fibroblast growth factor 21, Klotho, and diabetic retinopathy: a meta-analysis
    Jiang, Yanhua
    Zhang, Weilai
    Xu, Yao
    Zeng, Xiandong
    Sun, Xin
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15